Pharmacotherapeutic options for treating brain metastases in non-small cell lung cancer
G Metro, R Chiari, B Ricciuti, A Rebonato… - Expert Opinion on …, 2015 - Taylor & Francis
Introduction: Central nervous system (CNS) metastases represent an important cause of
morbidity and mortality in non-small cell lung cancer (NSCLC) patients. Local approaches of …
morbidity and mortality in non-small cell lung cancer (NSCLC) patients. Local approaches of …
Pharmacotherapeutic options for treating brain metastases in non-small cell lung cancer
G Metro, R Chiari, B Ricciuti, A Rebonato… - Expert Opinion on …, 2015 - hero.epa.gov
INTRODUCTION: Central nervous system (CNS) metastases represent an important cause
of morbidity and mortality in non-small cell lung cancer (NSCLC) patients. Local approaches …
of morbidity and mortality in non-small cell lung cancer (NSCLC) patients. Local approaches …
Pharmacotherapeutic options for treating brain metastases in non-small cell lung cancer.
G Metro, R Chiari, B Ricciuti, A Rebonato… - Expert Opinion on …, 2015 - europepmc.org
Central nervous system (CNS) metastases represent an important cause of morbidity and
mortality in non-small cell lung cancer (NSCLC) patients. Local approaches of neurosurgery …
mortality in non-small cell lung cancer (NSCLC) patients. Local approaches of neurosurgery …
Pharmacotherapeutic options for treating brain metastases in non-small cell lung cancer
G Metro, R Chiari, B Ricciuti… - Expert opinion on …, 2015 - pubmed.ncbi.nlm.nih.gov
Introduction Central nervous system (CNS) metastases represent an important cause of
morbidity and mortality in non-small cell lung cancer (NSCLC) patients. Local approaches of …
morbidity and mortality in non-small cell lung cancer (NSCLC) patients. Local approaches of …